Literature DB >> 7503206

Fetal responses to maternal and fetal methamphetamine administration in sheep.

A M Stek1, R S Baker, B K Fisher, U Lang, K E Clark.   

Abstract

OBJECTIVES: The current study was designed to test the hypothesis that maternally administered methamphetamine decreases fetal PaO2 by reducing uterine blood flow and to determine the cardiovascular and blood gas responses to varying doses of methamphetamine given both to the fetus and the mother. STUDY
DESIGN: Nine near-term pregnant sheep were surgically instrumented to measure maternal and fetal blood pressure and heart rate and uterine and umbilical blood flow. Fetal blood gases and pH were determined before and after each dose of methamphetamine. Methamphetamine was administered as intravenous bolus injections (30 to 35 minutes separating administration of each dose) into the maternal femoral vein in increasing doses of 0.03, 0.1, 0.3, and 1.0 mg/kg and on a separate days to the fetus into the hind limb vein as doses of 0.03, 0.1, 0.3, 1.0, and 3.0 mg/kg estimated fetal weight.
RESULTS: Maternal methamphetamine administration produced a dose-related increase in maternal and fetal blood pressure and uterine vascular resistance, whereas uterine blood flow decreased in a dose-related fashion. Umbilical blood flow tended to increase slightly, but this did not reach significance. Fetal PaO2 decreased significantly, whereas fetal pH decreased only modestly. Direct fetal administration of methamphetamine produced dose-related increases in fetal blood pressure and umbilical blood flow and a significant decrease in fetal pH but no change in fetal PaO2.
CONCLUSIONS: The fetal PaO2 decrease observed after maternal administration of methamphetamine appears to be a result of decreased uteroplacental perfusion, whereas the observed changes in fetal blood pressure and fetal pH appear to be a result of the direct action of methamphetamine on the fetus.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7503206     DOI: 10.1016/0002-9378(95)90654-1

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  14 in total

Review 1.  Neuroimaging of children following prenatal drug exposure.

Authors:  Chris Derauf; Minal Kekatpure; Nurunisa Neyzi; Barry Lester; Barry Kosofsky
Journal:  Semin Cell Dev Biol       Date:  2009-03-13       Impact factor: 7.727

Review 2.  Fetal effects of psychoactive drugs.

Authors:  Amy L Salisbury; Kathryn L Ponder; James F Padbury; Barry M Lester
Journal:  Clin Perinatol       Date:  2009-09       Impact factor: 3.430

3.  Intrauterine growth of infants exposed to prenatal methamphetamine: results from the infant development, environment, and lifestyle study.

Authors:  Diana Nguyen; Lynne M Smith; Linda L Lagasse; Chris Derauf; Penny Grant; Rizwan Shah; Amelia Arria; Marilyn A Huestis; William Haning; Arthur Strauss; Sheri Della Grotta; Jing Liu; Barry M Lester
Journal:  J Pediatr       Date:  2010-06-08       Impact factor: 4.406

4.  Prenatal methamphetamine exposure is associated with reduced subcortical volumes in neonates.

Authors:  Fleur L Warton; Ernesta M Meintjes; Christopher M R Warton; Christopher D Molteno; Nadine M Lindinger; R Colin Carter; Lilla Zöllei; Pia Wintermark; Joseph L Jacobson; Andre van der Kouwe; Sandra W Jacobson
Journal:  Neurotoxicol Teratol       Date:  2017-10-22       Impact factor: 3.763

5.  Prenatal methamphetamine exposure is associated with corticostriatal white matter changes in neonates.

Authors:  Fleur L Warton; Paul A Taylor; Christopher M R Warton; Christopher D Molteno; Pia Wintermark; Nadine M Lindinger; Lilla Zöllei; Andre van der Kouwe; Joseph L Jacobson; Sandra W Jacobson; Ernesta M Meintjes
Journal:  Metab Brain Dis       Date:  2017-10-23       Impact factor: 3.584

6.  Methamphetamine detection in maternal and neonatal hair: implications for fetal safety.

Authors:  F Garcia-Bournissen; B Rokach; T Karaskov; G Koren
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-10-31       Impact factor: 5.747

Review 7.  Structural, metabolic, and functional brain abnormalities as a result of prenatal exposure to drugs of abuse: evidence from neuroimaging.

Authors:  Florence Roussotte; Lindsay Soderberg; Elizabeth Sowell
Journal:  Neuropsychol Rev       Date:  2010-10-28       Impact factor: 7.444

8.  Prenatal methamphetamine use and neonatal neurobehavioral outcome.

Authors:  Lynne M Smith; Linda L Lagasse; Chris Derauf; Penny Grant; Rizwan Shah; Amelia Arria; Marilyn Huestis; William Haning; Arthur Strauss; Sheri Della Grotta; Melissa Fallone; Jing Liu; Barry M Lester
Journal:  Neurotoxicol Teratol       Date:  2007-10-03       Impact factor: 3.763

9.  Vulnerability to (+)-methamphetamine effects and the relationship to drug disposition in pregnant rats during chronic infusion.

Authors:  Sarah J White; Elizabeth M Laurenzana; William Brooks Gentry; Howard P Hendrickson; David Keith Williams; Keith W Ward; Samuel Michael Owens
Journal:  Toxicol Sci       Date:  2009-06-10       Impact factor: 4.849

Review 10.  Investigating Mechanisms of Stillbirth in the Setting of Prenatal Substance Use.

Authors:  Corrie B Miller; Tricia Wright
Journal:  Acad Forensic Pathol       Date:  2018-12-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.